|
Neurotechnology encompasses electrical, chemical, and medical devices and products that can interact with or intervene in the activity of the central nervous system. These technologies include neuroprosthetics, neuroengineering, neuroimaging, optogenetics, neuromodulation, and neural stem cell therapies. Translating neurotechnologies from the laboratory into clinical and commercial products has been an arduous process. Yet many of these new tools show great potential to revolutionize the treatment of neurological diseases and disorders including depression, pain, headache, epilepsy, neuromuscular disease, Alzheimer's disease, Parkinson's disease, and traumatic brain injury.
Through a series of plenary sessions, panel discussions, and interactive breakout groups, this 2.5-day international conference shall explore innovative scientific, clinical, and organizational models for advancing the translation of neuroscience research into technology that can dramatically improve diagnosis and treatment of neurological and psychiatric disease. Participants will also examine the ethical and regulatory challenges in translating neuroscience research, and the potential economic impact of their clinical application.
This conference includes a breakout session. During registration, you will be asked to choose a work group based on your area/disease of interest. Please pick your first and second choices for this session. You may also write in an alternate topic. We will create additional groups if there is sufficient interest. Registrants will receive an e-mail with work group details several weeks prior to the conference.
|
Home
From basic clinical research to case studies. 
Check out our upcoming Webinar: 
